C
CryoCell International Inc (CCEL)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • AMEX
$4.52
-0.33 (-6.80%)
Market Cap: $39.10M
Last updated: Nov 17, 2026 at 11:04 AM ET
CryoCell International Inc (CCEL) Valuation Multiples
CryoCell International (CCEL) trades at 1.2x sales. Its P/S of 1.2x is below its 5-year median of 1.4x.
Current Multiples
Its enterprise value is 34.3x its EBITDA. Its free cash flow yield is 12.8%.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 1.2x |
| EV/EBITDA | 34.3x |
| Price to FCF | 7.8x |
| EV/FCF | 9.5x |
| PEG | N/A |
| FCF yield | 12.8% |
Historical Medians
Against its 10-year medians, its P/S is 33.3% below 1.8x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 1.2x | 1.4x | 1.8x |
Valuation History
Over the 5 of the 9 year ends shown that have a P/E, its P/E ranged from 12.8x in 2022 to 98.1x in 2024. 2024 was the highest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $3.44 | N/A | 0.9x | N/A |
| 2024 | $7.41 | 98.1x | 1.9x | N/A |
| 2023 | $5.75 | N/A | 1.5x | N/A |
| 2022 | $4.23 | 12.8x | 1.2x | N/A |
| 2021 | $11.60 | 46.4x | 3.2x | 23.2x |
| 2020 | $7.70 | 17.1x | 1.9x | N/A |
| 2019 | $7.13 | N/A | 1.7x | N/A |
| 2017 | $9.67 | 14.0x | 2.6x | N/A |
| 2016 | $4.56 | N/A | 1.6x | N/A |
Frequently Asked Questions About CCEL
What is CCEL's price to sales ratio?
CryoCell International has a price to sales ratio of 1.2x.
CCEL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors